Figure 2.

Effect of itraconazole, 17‐OH itraconazole or remdesivir on SARS‐CoV‐2 vRNA yield and viability in Caco‐2 cells. (A) Mean differences in vRNA in the supernatant between untreated cultures and treated cultures at 48 h postinfection with SARS‐CoV‐2‐FFM1 of three independent experiments each containing two replicates is shown. Error bars represent the standard deviation. (B) Mean viability of the cells, based on three independent experiments each containing three replicates is shown. Error bars represent the standard deviation. SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; vRNA, viral RNA